Company news

CytomX Therapeutics, Inc. news in 2026

CytomX Therapeutics, Inc.'s news releases, calls and decks from 2026, newest first.

View company

CytomX Therapeutics Announces Q3 2026 Financial Results and Provides Business Update

November 5, 2026

CytomX Therapeutics to Present at Upcoming November Investor Conferences

November 2, 2026

CytomX Therapeutics to Report Third Quarter 2026 Financial Results on November 5, 2026

October 29, 2026

CytomX Therapeutics Announces FDA Fast Track Designation for Varsetatug masetecan (“Varseta-M”) for Relapsed/Refractory Metastatic Colorectal Cancer (R/R mCRC)

August 27, 2026

CytomX Therapeutics Announces Q2 2026 Financial Results and Provides Business Update

August 6, 2026

CytomX Therapeutics Appoints Alejandra Carvajal as Chief Legal Officer

August 3, 2026

CytomX Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026

July 30, 2026

CytomX Therapeutics Announces Appointment of Charles Fuchs, M.D., M.P.H., to the Board of Directors

July 27, 2026

CytomX Announces Expansion of Strategic Research Collaboration with Regeneron in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer

June 2, 2026

CytomX Therapeutics to Present at Upcoming June Investor Conferences

May 21, 2026

CytomX Therapeutics Appoints Mamata Gokhale, Ph.D., RAC, as Senior Vice President of Regulatory Affairs

May 18, 2026

CytomX Therapeutics Announces Q1 2026 Financial Results and Provides Business Update

May 7, 2026

CytomX Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026

April 30, 2026

CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants

March 16, 2026

CytomX Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

March 16, 2026

CytomX Therapeutics Announces 2025 Financial Results and Provides Business Update

March 15, 2026

CytomX Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026

March 3, 2026

CytomX Therapeutics to Present at Upcoming February Conferences

February 4, 2026

Wareham Development Leases Full Floor at EmeryStation Research Campus to CytomX Therapeutics

January 21, 2026

CytomX Therapeutics Announces Business Update and Company Milestones for 2026

January 7, 2026

Calls in 2026

Decks in 2026